CHP urges schoolchildren to promptly receive seasonal influenza vaccination as Hong Kong records its first fatal case of paediatric influenza infection this year
******************************************************************************************
"This is the first fatal case of paediatric influenza infection in Hong Kong since June last year. Hong Kong is currently in the summer influenza season and there has been a significant increase in influenza-like illness outbreaks in schools since September. As of October 10, 337 outbreaks have been reported in schools since the start of the school year in September, including 35 cases in kindergartens/child care centres, 182 cases in primary schools and 120 cases in secondary schools. Including the above case, nine severe and one fatal paediatric influenza cases involving children aged 3 to 17 have been recorded since the start of the school year. Eight of them had good past health," the Controller of the CHP, Dr Edwin Tsui, said.
The 2025/26 SIV Programmes have commenced, offering free or subsidised SIV to eligible high-risk groups through various vaccination programmes. This year, all schools may choose to use the live attenuated influenza vaccine (LAIV nasal vaccines) and "hybrid mode", i.e. schools are allowed to choose both injectable inactivated influenza vaccines and LAIV for the same or different outreach vaccination activities.
"Seasonal influenza activity is also rising in neighbouring regions beyond Hong Kong. Japan has declared the onset of its influenza season, which is earlier than last year. As influenza viruses constantly mutate, the influenza vaccine must be updated annually. Even if individuals received the SIV last season, they should still get the latest vaccine for the new season to ensure protection against the current strain of influenza. Influenza can cause serious illnesses in high-risk individuals and even in healthy persons. SIV is one of the most effective ways of preventing seasonal influenza and its complications, as well as reducing influenza-related hospitalisation and death. The SIV is recommended for all persons aged six months or above, except those with known contraindications. Those at higher risk of contracting influenza and its complications, including the elderly and children, should receive the SIV as soon as possible." Dr Tsui added.
Dr Tsui reminded the public that, if they develop a fever and respiratory symptoms, especially among children, elderly and those with chronic conditions, they should seek medical attention promptly for early treatment. High-risk individuals should wear surgical masks when staying in crowded places. People with respiratory symptoms, even if mild, should wear a surgical mask and seek medical advice promptly. They should also consider whether to attend work or school.
For the latest information on seasonal influenza, members of the public can visit the CHP's seasonal influenza and COVID-19 & Flu Express webpages.
Ends/Sunday, October 12, 2025
Issued at HKT 18:45
Issued at HKT 18:45
NNNN